Group One Trading’s Jasper Therapeutics JSPR Stock Holding History

Group One Trading’s Portfolio JSPR Stock Details JSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.39K	Buy	19,930 +19,045	+2,152%	+$14.3K	﹤0.01%	6504
2026 Q1	$775	Buy	885 +97	+12%	+$135	﹤0.01%	7253
2025 Q4	$1.44K	Sell	788 -16,762	-96%	-$33.6K	﹤0.01%	7639
2025 Q3	$41.8K	Buy	+17,550	New	+$53.2K	﹤0.01%	6116
2025 Q1	–	Sell	-500	Closed	-$3.33K	–	7976
2024 Q4	$10.7K	Buy	+500	New	+$10.4K	﹤0.01%	6069
2024 Q1	–	Hold	0	–	-$1	–	7493
2023 Q4	–	Hold	0	–	–	–	7273
2023 Q3	–	Sell	-829	Closed	-$10.1K	–	7543
2023 Q2	$11.4K	Buy	+829	New	+$12.3K	﹤0.01%	6328
2023 Q1	–	Sell	-30	Closed	-$555	–	7566
2022 Q4	$143	Hold	30	–	–	﹤0.01%	7055
2022 Q3	$0	Sell	30 -10	-25%	-$183	﹤0.01%	7866
2022 Q2	$1K	Buy	+40	New	+$1.14K	﹤0.01%	7559

Other funds holding JSPR

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Group One Trading's JSPR Position: Q2 2026 in Review

Group One Trading increased its Jasper Therapeutics (JSPR) stake by 2,152% in Q2 2026, buying an estimated $14.3K and bringing the position to 19,930 shares worth $8.39K. The position accounts for ﹤0.01% of the portfolio, ranked #6504.

Group One Trading first reported a position in JSPR in Q2 2022 and has held it in 9 quarters since. The position peaked at $41.8K in Q3 2025. 45 funds tracked by Wall St. Rank hold JSPR as of Q2 2026.

Group One Trading held 19,930 shares of Jasper Therapeutics worth $8.39K as of Q2 2026.
Group One Trading bought 19,045 Jasper Therapeutics shares in Q2 2026, an estimated $14.3K.
Jasper Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6504 holding.
Group One Trading first reported a position in Jasper Therapeutics in Q2 2022 and has held it in 9 quarters since.
Group One Trading's Jasper Therapeutics position peaked at $41.8K in Q3 2025.
45 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.